Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Receivables - Other (2019 - 2026)

Adagene (ADAG) posted quarterly Receivables - Other of $17.3 billion for Q4 2025, up 108.8% year-over-year from $8.3 billion in Q4 2024, and up 296057920.48% quarter-over-quarter from $5860.0 in Q2 2025.

Analysis

Adagene (ADAG) Receivables - Other (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Receivables - Other for 7 consecutive years, with $17.3 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Receivables - Other rose 108.8% year-over-year to $17.3 billion; the TTM figure through Dec 2025 stood at $17.3 billion (up 108.8% YoY), while the FY2025 annual figure was $17.3 billion, up 108.8% from the prior year.
  • Receivables - Other rose to $17.3 billion in Q4 2025 per ADAG's latest filing, from $5860.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1870.1 billion in Q2 2022 and bottomed at $5860.0 in Q2 2025.
  • Historically, Receivables - Other has averaged $313.1 billion across 5 years, with a median of $12.8 billion in 2024.
  • Annual changes were most pronounced in 2022 — Receivables - Other jumped 201428797.64% — and 2024, when it sank 100.0%.
  • Adagene's Receivables - Other stood at $4.5 million in 2021, then jumped by 13744682.73% to $619.4 billion in 2022, then sank by 64.16% to $222.0 billion in 2023, then tumbled by 96.26% to $8.3 billion in 2024, then jumped by 108.8% to $17.3 billion in 2025.
  • Business Quant data shows ADAG's Receivables - Other at $17.3 billion in Q4 2025, $5860.0 in Q2 2025, and $8.3 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,025.00
Dec 31, 2025 17,349.00
Jun 30, 2025 5,860.00
Dec 31, 2024 8,309.00
Jun 30, 2024 190,608.00
Dec 31, 2023 397,405.00
Jun 30, 2023 393,969.00
Dec 31, 2022 3.89 Mn
Jun 30, 2022 1.87 Mn
Dec 31, 2021 -4.37 Mn
Jun 30, 2021 928,408.00
Dec 31, 2020 1.30 Mn
Dec 31, 2019 -704,253.00